FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/31/2023
Back to search
Official data from USPTO
COVIRUPT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COVIRUPT
ST13
US500000079339131Class
1, 5, 42
Filing
79339131
Registration
7095487
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
10/31/2023
Trademark type
Word
Nice classes
1, 5, 42
Filing date
08/11/2021
Registration date
07/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/04/2023
Last transaction
07/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
LI
Examiner
LE, KHANH M
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Lysando AG
Representatives
Alan M. Weisberg CHRISTOPHER & WEISBERG, P.A.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
biochemical and biological preparations and reagents for scientific useother than for medical or veterinary purposes; biological preparations for industrial useother than for medical or veterinary purposes; reagents for industrial research purposesother than for medical or veterinary purposes; biochemical and biological preparations and reagents for research and development in the fields of human and veterinary medicinepharmacybiology and biotechnology; industrial detergents for use in manufacturing processes; detergents for use in industrial manufacturing processes; active biochemical and biological ingredients for use in the manufacture of pharmaceutical preparations for treating viruses; active biochemical and biological additives for use in the manufacture of medical dressings; biochemical and biological additives for use in the manufacture of medicinepharmaceutical preparationsmedical dressings and plasterspersonal care products and sanitary products; biochemical and biological additives and active biochemical and biological ingredients for use in the manufacture of medicines and pharmaceuticals for treating viral infectionsmedical dressings and plasterspersonal care products and sanitary products; biochemical and biological preparationsfor use in the manufacture of pharmaceuticals for treating viral infections; biochemical and biological raw materials for use as active ingredients in the manufacture of pharmaceutical preparations for treating viral infections; biochemical and biological preparations having antimicrobial and/or virucidal properties for scientific research purposes and other than for medical or veterinary purposes; biologicalbiochemical and biotechnological substances for use as additives in the manufacture of personal care products
Class 5
Medicines for the treatment of viral infections; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations in the form of aqueous solutioninhalation solutioninjectable solutions for use in the treatment of viral infections; pharmaceuticals in the form of medicated creamslotionsointments for dermatological use; preparations against infectious agentsdisinfectants; sanitary preparations for medical and veterinary purposes; medicated virucidal mouth and throat washes; medicated products for the treatment of viral infectionsmouth and throat spraysnasal spraysnasal oilsnasal ointmentsnasal creams and nasal drops for medical and veterinary purposes; medicated lozenges for medical purposes; skin disinfectant; medicated skin care preparations; antiseptic wipes for medicalveterinary and surgical purposes; disinfectants; wipes and medical dressings impregnated with disinfectants or virucidal pharmaceutical solutions; disinfecting biochemical and biological preparations for medical and veterinary purposes; virucides for medical or veterinary purposes; polypeptidesnucleic acidsproteinslipidsenzymes and enzyme preparations for medicalveterinary and disinfection purposes; medicated eye washesmedicated eye drops and additives for medicated eye washes and medicated eye drops; animal feed additives for treating infectious diseases; germicides; cleansing preparations with disinfecting effect for hygienic purposes; medicated animal and livestock washes
Class 42
Scientific research in the field of pharmaceuticals; research and development services and research work in the fields of medicinepharmacybacteriologyvirologyhealth productscosmetics and food supplements; research and development consultancyin particular in the fields of medicinepharmacybacteriologyvirologyhealth productscosmetics and food supplements; industrial analytical and research servicesin particular in the fields of antimicrobial and virucidal analysis and research
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/06/2023
FIMP
FINAL DISPOSITION PROCESSED
10/06/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2023
GPNX
NOTIFICATION PROCESSED BY IB
04/25/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2023
PUBO
PUBLISHED FOR OPPOSITION
04/18/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/03/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/11/2023
GNFR
FINAL REFUSAL E-MAILED
01/11/2023
CNFR
FINAL REFUSAL WRITTEN
01/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/14/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2022
RFNT
REFUSAL PROCESSED BY IB
07/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2022
RFRR
REFUSAL PROCESSED BY MPU
06/15/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/18/2022
CNRT
NON-FINAL ACTION WRITTEN
05/17/2022
DOCK
ASSIGNED TO EXAMINER
05/12/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/29/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/28/2022
Continuous trademark protection
Get notified about every new filing that threatens COVIRUPT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.